Portugal’s medicines regulator has defended a year of tightened oversight and extended licensing delays throughout the country’s medical cannabis sector, telling operators that export certificates are now issued within 12 days and that the enforcement which unsettled the market stemmed from record-keeping and traceability failures rather than problems with the product itself.
Cannabis Europa London returns on 26-27 May 2026, bringing together operators, investors, clinicians, and policymakers from across the global cannabis industry for two days of main-stage debate, exhibition, and networking.
Canadian producers shipped 17,067kg of medical cannabis directly to the UK in 2025, more than six times the 2,578kg recorded the year before, according to the latest official Home Office data seen by Business of Cannabis.
Cannabis Europa London returns on 26-27 May 2026, bringing together operators, investors, clinicians and policymakers from across the global cannabis industry for two days of main stage debate, exhibition, and networking.
For many, last week’s rescheduling announcement threw a spanner in the works.
As the European cannabis conference season gets started, industry experts, lawmakers, regulators and business owners are facing greater mainstream scrutiny than ever before.
Canadian cannabis exports totalled CA$51.6 million in February 2026 across the three main cannabis HS codes tracked in export data, up 8.7% on the same month a year earlier.
Spain’s medicines agency has published the first official guidance for medical cannabis preparations, confirming that its incoming market will exclude raw cannabis flower in favour of ‘standardised’ oral solutions prepared exclusively in hospital pharmacies.
The ongoing battle to rescue the US hemp industry has reached boiling point, as the 2026 spending bill continues to advance.
